Full-Time

Senior Director

Business Development

Updated on 3/14/2025

Medable

Medable

201-500 employees

Digital platform for conducting clinical trials

No salary listed

Senior, Expert

United Kingdom

Category
Business Development
Business & Strategy
Required Skills
Sales
Salesforce
Data Analysis
Requirements
  • Excellent analytical and time-management skills
  • Demonstrated and proven sales results
  • Ability to work independently or as an active member of a team
  • High-level communication skills
  • Stakeholder management skills
  • Proven ability to negotiate
  • The ability to self-motivate
  • Experience working to and exceeding targets
  • Excellent verbal and written communication skills; the ability to call, connect, and interact with potential customers
  • Persuasive and goal-oriented
  • Experience selling to Pharmaceutical, Biotechnology, CRO or other life sciences companies
  • 12+ years of experience in business development or a combination of education and experience
  • BS degree in business administration, economics, life sciences or a related field
  • Microsoft Office, CRM/Salesforce experience.
Responsibilities
  • Handle Business Development for a Clinical Trial technology data collection and analytics unified platform
  • Call on the C Suite, clinical development, clinical operations, and clinical outsourcing at large pharmaceutical and biotech companies
  • Manage a territory that includes several named large pharmaceutical accounts and companies
  • Other duties as assigned
Desired Qualifications
  • Preferred Degree/Certification: MBA / Master´s degree

Medable offers a digital platform that streamlines the clinical trial process for pharmaceutical companies and other organizations. It provides tools for participant onboarding, data collection, study notifications, and real-time reporting, ensuring high-quality data for validating drug effectiveness. Medable stands out with its user-friendly design, scalability, and extensive decentralized clinical trial network, operating in over 60 countries and 120 languages. The company's goal is to leverage the growing decentralized clinical trial market, projected to exceed $12 billion by 2030.

Company Size

201-500

Company Stage

Series D

Total Funding

$506.2M

Headquarters

Palo Alto, California

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Integration with Google Cloud enhances scalability and global accessibility.
  • Generative AI reduces trial startup time, improving efficiency and patient outcomes.
  • CNIL approval expands opportunities for digital trials across the European Union.

What critics are saying

  • AI-driven SaaS competition could threaten Medable's market share.
  • Dependency on Google Cloud poses operational risks if disruptions occur.
  • Rapid AI adoption may lead to data privacy and security concerns.

What makes Medable unique

  • Medable offers a unified platform for decentralized clinical trials globally.
  • The platform supports 60+ countries and 120 languages, enhancing global reach.
  • Medable's no-code platform empowers non-technical users to design complex trials.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health & wellness

401k

Remote first

Career development

Military support

Time away

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
HR Tech Wire
Mar 4th, 2025
Medable Achieves Landmark CNIL Approval, Expanding Access for Digital Clinical Trials Across the European Union

Medable partnered closely with Servier - one of the largest pharmaceutical sponsors in France - over six months to obtain CNIL approval.

PYMNTS
Dec 12th, 2024
Ai Opens Gold Rush In Niche Business Software Markets

Silicon Valley investors are seeing a wave of opportunities in specialized software for laundromats, chiropractors and other previously overlooked industries as artificial intelligence improves profit potential. The shift comes as AI technology allows software companies to expand from basic business management tools into handling sales, marketing and customer service tasks that were once too complex to automate, potentially increasing revenue per customer tenfold while slashing acquisition costs, according to new research from venture capital firm Andreessen Horowitz. “In vertical SaaS, AI is making previously unprofitable markets viable by increasing customer value and driving down costs,” VisionX founder and CEO Antwyne DeLonde told PYMNTS. “With AI automating complex tasks and delivering personalized solutions, software companies can now serve smaller, niche markets that were once financially out of reach.”

BioPharmaTrend
Nov 14th, 2024
Medable Adds Generative AI to Simplify and Speed Up Clinical Trials

Medable Inc. has introduced generative AI capabilities to its Medable Studio platform to streamline and accelerate digital and decentralized clinical trial workflows.

Outsourcing-Pharma
Nov 13th, 2024
Medable and Google Cloud partner to deliver digital clinical trials technology

Medable's platform will be seamlessly integrated with Google Cloud Marketplace, which will enable users to access Medable's recently launched Studio, a software as a service (SaaS) solution designed to provide pharmaceutical companies control and transparency in clinical trial design, execution, and data management.

Hit Consultant
Nov 12th, 2024
Medable Unveils Generative Ai To Accelerate Clinical Trial Startup

What You Should Know:– Medable Inc., a leader in clinical development technology, has announced Medable AI, a suite of generative AI capabilities designed to revolutionize the clinical trial startup process. Medable AI empowers sponsors and clinical research organizations (CROs) to build digital and decentralized trials faster, with greater efficiency and control.– The launch of Medable AI is part of a broader AI strategy for Medable, with plans to expand AI capabilities across its platform in the future. This reflects the company’s commitment to leveraging cutting-edge technology to accelerate clinical development and improve patient outcomes.Accelerating Time to First Patient In (FPI)Medable AI, integrated into the Medable Studio platform, automates time-consuming manual tasks that traditionally slow down clinical trial startup. By streamlining processes and eliminating repetitive work, Medable AI significantly reduces the time to First Patient In (FPI).For example, building multiple outcomes assessments for a study, a process that typically takes days, can now be completed in just 30 minutes with Medable AI, according to early metrics. This accelerated timeline represents a major breakthrough for the industry, moving towards the ambitious goal of one-day study startup.Enhanced Efficiency and ControlMedable AI offers a range of capabilities to enhance the trial build process:Automated eCOA Creation: Automatically converts existing outcomes assessments into fully digital eCOAs in seconds.Automatically converts existing outcomes assessments into fully digital eCOAs in seconds. Simplified Editing: Provides a user-friendly, ChatGPT-like interface for easy editing of assessments.Provides a user-friendly, ChatGPT-like interface for easy editing of assessments